Pfizer’s New Covid-19 Pill Works Against Omicron in Lab

The drug’s main component worked in three separate laboratory studies, a potentially encouraging sign as the Omicron strain spreads.

The Wall Street Journal | I+D | Salud |

Leer noticia completa en el medio original
Spanish